ADJUVANT COMPOSITION CONTAINING DYSLIPIDEMIA THERAPEUTIC AGENT

摘要

PROBLEM TO BE SOLVED: To provide a new adjuvant alternative to a conventional alum adjuvant widely used, specifically, an adjuvant having high effect of enhancing immunogenicity of an antigen and also being abundant in safety to human bodies.SOLUTION: An adjuvant containing a dyslipidemia therapeutic agent results in adjuvant effect equal to or higher than an alum adjuvant. In addition, the dyslipidemia therapeutic agent is used as a pharmaceutical by a large number of people so it has excellent safety to human bodies. Therefore, the adjuvant containing a dyslipidemia therapeutic agent of the present invention is excellent in antibody producibility and safety.